2016—2021年某医院住院费用结构及变动情况分析

Analysis on the composition and changes of inpatient costs in a hospital from 2016 to 2021

目的了解2016—2021年某院次均住院费用内部构成及变化,为降低住院医疗负担及促进中医药事业的高质量发展提供实证依据。方法运用灰色关联分析法及结构变动度分析法进行统计分析。结果2016—2021年某院次均住院费用逐年增加,年均增长3.46%;从灰色关联性来看,诊断类费用是关联性最大的项目;2016—2021年某院次均住院费用的总体结构变动度为32.77%,西药类、耗材类及诊断类费用是造成住院费用结构变动的主要因素,三者累积贡献率为73.97%。结论该院在控制西药类费用方面成效显著,但次均住院费用增速需要进一步降低,诊断类和耗材类费用是控制住院费用的重点;需要进一步提升中医类费用比重,推进中药类费用和西药类费用的平衡,突出中医特色优势;需要进一步提高体现医护人员劳务价值费用的占比。

Objective To understand the internal composition and changes of average inpatient costs in a hospital from 2016 to 2021,so as to provide empirical basis for reducing the inpatient burden and promoting the high-quality development of traditional Chinese medicine.Methods The grey correlation analysis and the structure variation analysis were used for statistical analysis.Results From 2016 to 2021,inpatient costs increased with an average annual growth rate of 3.46%.From the perspective of grey correlation,the diagnostic cost was the item with the greatest correlation.The structure variation of inpatient costs was 32.77%from 2016 to 2021.Causing the change of cost structure mainly included three major items:Western medicine costs,consumable costs and diagnostic costs with the cumulative contribution rate of 73.97%.Conclusion In controlling the cost of western medicine,the hospital had achieved remarkable results,but the growth rate of per inpatient cost needs to be further reduced,and the diagnostic costs and consumable costs are the key to control the cost of inpatients.It is necessary to further increase the proportion of traditional Chinese medicine costs,promote the balance between herbal medicine costs and western medicine costs,and highlight the advantages of traditional Chinese medicine.It is necessary to further increase the proportion of the cost reflecting the service value of medical staff.